Last Price | 90.56 | Max Price | 105.60 |
Min Price | 82.08 | 1 Year return | -30.55 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Annual report 2014 |
Contact info:Zip Code: 13040City: SaluggiaCountry: ItalyPhone: 39 0161 487.1Email: info@diasorin.comWebsite: www.diasorin.comCEO: Carlo RosaCFO: Pier Luigi De Angelis
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 706 | 2,019,627 | 0.03 % |
2020 | 881 | 2,170,562 | 0.04 % |
2021 | 1,238 | 2,404,921 | 0.05 % |
2022 | 1,361 | 2,645,840 | 0.05 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the last 12 months (from December 2015 till December 2016), that were profitable period for the investors in Diasorin, the stock gained around 15 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 185 percent. Diasorin's revenues between 2011 and 2015 were very constant and moved between 433,76 million euros and 499,18 million euros. During 2011 and 2015 Diasorin's net results were very volatile and fluctuated between 99,61 million euros and 100,55 million euros.
Diasorin's headquarter is located in Saluggia. Diasorin's core business is the health care eq. & services sector. Carlo Rosa leads the company as CEO. The CFO of the company is Pier Luigi De Angelis. Between 2006 and 2016 the global health care companies gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.
The Italian company paid out dividends in the past 5 years. On average Diasorin's dividend yield over the past 5 years was around 2,76 percent annually.
At the end of 2015 the health care company's balance sheet equaled 707,91 million euros. The total debt of the health care company was at the end of 2015 121,1 million euros, which equals around 17,11 percent of the total balance sheet. As per the end of 2015 Diasorin's price/earnings-ratio equaled 18. So investors paid for 1 stock 18 times the earnings per share of 2015. Based on the classical stock valuation theories the Italian stock can be seen as a value stock.
At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 2,66 billion euros. At the end of 2015 the Italian company had around 54,88 million stocks listed on the stock exchange(s).
On this page you can find all Diasorin's financial reports. More information about Diasorin can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
499
|
569
|
637
|
669
|
706
|
881
|
Costs |
399
|
457
|
498
|
511
|
531
|
633
|
Profit |
100
|
112
|
140
|
158
|
176
|
248
|
Margin of profit |
20.12
|
19.74
|
21.94
|
23.63
|
24.88
|
28.13
|
ROI |
17.11
|
16.95
|
18.87
|
22.44
|
20.71
|
25.96
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
587
|
663
|
741
|
705
|
849
|
955
|
Debt |
121
|
206
|
204
|
201
|
215
|
292
|
Total assets |
708
|
869
|
946
|
906
|
1,064
|
1,246
|
Solvency |
82.89
|
76.31
|
78.40
|
77.79
|
79.79
|
76.59
|
Cash |
270
|
130
|
173
|
97
|
202
|
340
|
Cashflow |
138
|
166
|
167
|
210
|
233
|
305
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
1.14
|
0.80
|
0.82
|
1.04
|
1.08
|
1.04
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
47.25
|
54.85
|
72.16
|
70.70
|
115.40
|
Eps |
2.05
|
2.54
|
2.85
|
3.20
|
4.50
|
Price/earnings-ratio |
23.05
|
21.59
|
25.32
|
22.09
|
20.12
|
Dividend |
0.80
|
0.85
|
0.90
|
0.95
|
1.00
|
Dividend % |
1.69 %
|
1.55 %
|
1.25 %
|
1.34 %
|
1.10 %
|
Payout % |
0.39
|
0.33
|
0.32
|
0.30
|
0.22
|
Book value |
12.10
|
13.38
|
12.89
|
15.49
|
17.45
|
Market to book |
0.26
|
0.24
|
0.18
|
0.22
|
0.19
|
Cashflow per stock |
3.02
|
3.02
|
3.84
|
4.25
|
5.57
|
Stocks |
55
|
55
|
55
|
55
|
55
|
Market Cap |
2.587.33
|
3.038.66
|
3.944.06
|
3.873.70
|
4.955.64
|
Date
|
Price
|
---|---|
22 Apr 2024
|
90.56
|
18 Apr 2024
|
90.56
|
17 Apr 2024
|
87.36
|
09 Apr 2024
|
88.78
|
05 Apr 2024
|
83.92
|
03 Apr 2024
|
86.18
|
30 Mar 2024
|
89.50
|
22 Mar 2024
|
89.04
|
18 Mar 2024
|
93.48
|
15 Mar 2024
|
95.64
|
12 Mar 2024
|
94.66
|
11 Mar 2024
|
97.00
|
09 Mar 2024
|
97.00
|
07 Mar 2024
|
93.70
|
01 Mar 2024
|
93.38
|
29 Feb 2024
|
94.56
|
27 Feb 2024
|
95.60
|
22 Feb 2024
|
92.92
|
21 Feb 2024
|
92.46
|
20 Feb 2024
|
89.44
|
15 Feb 2024
|
86.78
|
14 Feb 2024
|
86.76
|
13 Feb 2024
|
87.78
|
09 Feb 2024
|
86.10
|
08 Feb 2024
|
86.10
|
07 Feb 2024
|
85.22
|
06 Feb 2024
|
84.96
|
05 Feb 2024
|
84.46
|
01 Feb 2024
|
85.54
|
31 Jan 2024
|
85.54
|